The purpose of this study is to establish the efficacy and safety of repeated monthly dosing of endothelial progenitor cells (EPCs) transfected with human endothelial NO-synthase (eNOS) in patients with symptomatic severe pulmonary arterial hypertension (PAH) on available PAH-targeted medical therapy.
Visit ClinicalTrials.gov for more information.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.